Abstract 1606P
Background
Sarcopenia refers to the loss of muscle mass and strength that occurs with aging and due to some medical conditions like cancer. Depression and inability to eat without assistance are common effects documented in cancer patients with sarcopenia. As a result, the goal of this study was to look into the relationship between sarcopenia, depression, and modes of feeding.
Methods
During the period beginning in January 2023 and ending in April 2023, cancer patients participated in a retrospective study. There has been a total of 150 participants enrolled in the trial, all of whom have been diagnosed with cancer. These people were enrolled in Mayo Hospital's Palliative Care Cancer Department in order to receive treatment. The Patient Health Questionnaire (PHQ-9) was used to determine the presence of depressive symptoms. The SARC-F was utilized to assess sarcopenia across all five dimensions. A self-report measure was utilized to assess modes of feeding [options include: 1) unable to eat without assistance 2) (self-fed with some difficulty, and 3) self-fed without any problem]. Sarcopenia, major depressive disorder, and feeding modes were studied using correlation analysis.
Results
We have observed a significant and negative association between modes of feeding and depression (r=-0.459, p<0.01), SARC1=Strength (r = -0.326, p<0.01), SARC2=Assistance in walking (r = -0.196, p<0.05), and SARC3=Rise from a chair (r = -0.238, p<0.01). These findings show that cancer patients are unable to eat without assistance when they suffer from sarcopenia which ultimately leads to more depressive symptoms.
Conclusions
Sarcopenia has a negative impact on the quality of life of patients, leading to depression and dependence on daily activities like self-eating which further complicates management.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
1615P - Investigation of status of lung cancer palliative care management and concept and practice in Chinese medical providers
Presenter: Liling Ma
Session: Poster session 05
1845P - Exclusion of patients with psychiatric disorders from early phase oncology trials: A limited access to innovation?
Presenter: Paul Matte
Session: Poster session 05
1846P - The impact of newly diagnosed early breast cancer on distress, perception of health and psychologic resilience
Presenter: Anuska Budisavljevic
Session: Poster session 05
1847P - Monitoring of psychological state and quality of life during Simonton-training for oncologic patients
Presenter: Petra Harasztosi
Session: Poster session 05
1849P - Use of antipsychotic drugs during radiotherapy in adult cancer patients in Korea: The nationwide retrospective cohort study based on the health insurance review and assessment service database
Presenter: JIN HWA CHOI
Session: Poster session 05
1851P - Psychological well-being of patients with colorectal cancer during the third wave of the COVID-19 pandemic: Results from cohort II of the PICO-SM study
Presenter: Konstantinos Kamposioras
Session: Poster session 05
1852P - Mental health among Tunisian oncologists
Presenter: nefzi issaad
Session: Poster session 05
1853P - Effect of logotherapy on anxiety in patients with cancer: A systematic review and meta-analysis
Presenter: Douglas Barroso
Session: Poster session 05
1854P - The role of “1 minute” time perception in evaluating depression and anxiety in cancer patients receiving chemotherapy
Presenter: Sait Kitaplı
Session: Poster session 05
1855P - Assessment of depression and anxiety among adult patients with solid tumours admitted in national institute of cancer research & hospital
Presenter: Salman Al Ayub
Session: Poster session 05